Following a full submission
AWMSG advice |
|||
| Status: Recommended with restrictions | |||
Green tea leaf extract (Catephen®) is recommended as an option for restricted use within NHS Wales. Green tea leaf extract (Catephen®) is licensed for the cutaneous treatment of external genital and perianal warts (condylomata acuminata) in immunocompetent patients from the age of 18 years. Green tea leaf extract (Catephen®) is restricted for use in patients not suitable for podophyllotoxin or who have not responded to treatment with podophyllotoxin. Green tea leaf extract (Catephen®) is not recommended for use within NHS Wales outside of this subpopulation. |
|||
|
|||
Medicine details |
|||
| Medicine name | green tea leaf extract (Catephen®) | ||
| Formulation | 10% ointment | ||
| Reference number | 2739 | ||
| Indication | Cutaneous treatment of external genital and perianal warts (condylomata acuminata) in immunocompetent patients from the age of 18 years |
||
| Company | Kora Corporation Ltd trading as Kora Healthcare | ||
| BNF chapter | Skin | ||
| Submission type | Full | ||
| Status | Recommended with restrictions | ||
| Advice number | 2416 | ||
| NMG meeting date | 20/07/2016 | ||
| AWMSG meeting date | 21/09/2016 | ||
| Ratification by Welsh Government | 04/10/2016 | ||
| Date of issue | 05/10/2016 | ||
| Date of last review | August 2020 | ||